Biocon Biologics starts clinical trial of drug for severe covid-19 complications In 2013, the company had received DCGI approval for the drug after successful clinical studies including a Phase 3 study in plaque psoriasis, and it launched the product under the brand Alzumab
In 2013, the company had received DCGI approval for the drug after successful clinical studies including a Phase 3 study in plaque psoriasis, and it launched the product under the brand Alzumab
from Livemint - Science https://ift.tt/2ZUEyTU
https://ift.tt/eA8V8J
from Livemint - Science https://ift.tt/2ZUEyTU
https://ift.tt/eA8V8J
Comments
Post a Comment